查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2153497

全球生物分析服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Bioanalytical Services Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 203 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球生物分析服務市場預計將從2025年的40.5億美元成長至2034年的109.9億美元，2026年至2034年的複合年成長率（CAGR）為11.73%。全球生物分析服務市場經歷了顯著成長，這主要得益於製藥和生物技術產業對藥物研發和臨床研究需求的不斷成長。慢性病盛行率的上升以及生物製藥和生物相似藥的擴張，顯著增加了對精準生物分析檢測的需求。有關藥品安全性和有效性的監管要求進一步強化了對專業分析服務的需求。質譜和層析法技術的進步提高了靈敏度和效率，使服務供應商能夠處理複雜的生物檢體，並支援全球範圍內的大規模臨床試驗。

主要成長要素包括製藥公司為降低營運成本和縮短產品上市時間而大幅增加的外包活動。特別是中小型生物技術公司，它們依賴合約研究組織（CRO）來獲取生物分析檢測方面的專業知識。個人化醫療和基於生物標記的研究日益普及，進一步推動了對先進分析平台的需求。此外，政府對生命科學研究的資助以及新興經濟體臨床試驗計畫的拓展，也顯著促進了市場成長，並推動了研究機構與服務供應商之間的策略合作。

展望未來，自動化、人工智慧驅動的數據分析和高通量篩檢技術的創新有望推動該市場的發展。資料管理和法規遵循數位平台的整合將進一步簡化工作流程。細胞和基因療法的發展預計將帶來新的成長機遇，因為精準的生物分析檢驗至關重要。隨著藥物研發管線日益多元化以及全球監管力度的加強，未來幾年對可靠、擴充性且技術先進的生物分析服務的需求將持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球生物分析服務市場：依服務類型分類

  • 市場分析、洞察與預測
  • 免疫化學服務
  • 定量免疫檢測
  • 基於細胞的中和試驗
  • LCMS方法的開發
  • 藥物發現階段的生物分析
  • LCMS樣品生物分析
  • GCP生物分析服務
  • 生物標記檢測
  • 蛋白質分析
  • 其他

第5章 全球生物分析服務市場：按類型分類

  • 市場分析、洞察與預測
  • 低分子量生物分析
  • 聚合物生物分析
  • 其他

第6章 全球生物分析服務市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 受託研究機構
  • 其他

第7章 全球生物分析服務市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Labcorp
    • Thermo Fisher Scientific Inc.（PPD）
    • Charles River Laboratories International Inc
    • Eurofins Scientific
    • ICON Plc
    • IQVIA Inc
    • SGS SA
    • Syneos Health
    • WuXi AppTec
    • Intertek Group Plc
    • Medpace HoldingsInc
    • Pace Analytical Services LLC
    • Frontage Laboratories Inc
    • BioAgilytix Labs
    • Altasciences
    • Almac Group
    • Celerion
    • Pharmaron
    • LGC Limited
    • KCAS Bioanalytical And Biomarker Services
簡介目錄
Product Code: VMR11210212

The global bioanalytical services market size is expected to reach USD 10.99 Billion in 2034 from USD 4.05 Billion in 2025, growing at a CAGR of 11.73% during 2026-2034.The Global Bioanalytical Services Market has experienced substantial growth due to the rising demand for drug development and clinical research across pharmaceutical and biotechnology industries. Increasing prevalence of chronic diseases and the expansion of biologics and biosimilars have significantly boosted the need for accurate bioanalytical testing. Regulatory requirements for drug safety and efficacy have further strengthened the demand for specialized analytical services. Technological advancements in mass spectrometry and chromatography techniques have improved sensitivity and efficiency, enabling service providers to handle complex biological samples and support large-scale clinical trials worldwide.

Key growth drivers include the surge in outsourcing activities by pharmaceutical companies aiming to reduce operational costs and accelerate time-to-market. Small and mid-sized biotech firms particularly rely on contract research organizations for bioanalytical testing expertise. The increasing adoption of personalized medicine and biomarker-based studies has also intensified demand for advanced analytical platforms. Moreover, government funding for life sciences research and expanding clinical trial pipelines in emerging economies contribute significantly to market expansion, fostering strategic collaborations between research institutions and service providers.

Looking ahead, the market is expected to benefit from innovations in automation, artificial intelligence-driven data analysis, and high-throughput screening technologies. The integration of digital platforms for data management and regulatory compliance will further streamline workflows. Growth opportunities are likely to emerge from cell and gene therapy development, where precise bioanalytical validation is essential. As pharmaceutical pipelines diversify and regulatory scrutiny increases globally, the demand for reliable, scalable, and technologically advanced bioanalytical services will continue to strengthen in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Service

  • Immunochemistry Services
  • Quantitative Immunoassays
  • Cell-based Neutralization Assays
  • LCMS Method Development
  • Discovery Phase Bioanalysis
  • LCMS Sample Bioanalysis
  • GCP Bioanalysis Service
  • Biomarker Assays
  • Protein Analysis
  • Others

By Type

  • Small Molecule Bioanalysis
  • Large Molecule Bioanalysis
  • Others

By End-user

  • Pharma & Biotechnology Companies
  • Contract Research Organizations
  • Others

COMPANIES PROFILED

  • Labcorp, Thermo Fisher Scientific Inc. (PPD), Charles River Laboratories International Inc., Eurofins Scientific, ICON plc, IQVIA Inc., SGS SA, Syneos Health, WuXi AppTec, Intertek Group plc, Medpace Holdings, Inc., Pace Analytical Services LLC, Frontage Laboratories Inc., BioAgilytix Labs, Altasciences, Almac Group, Celerion, Pharmaron, LGC Limited, KCAS Bioanalytical and Biomarker Services

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOANALYTICAL SERVICES MARKET: BY SERVICE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Service
  • 4.2. Immunochemistry Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Quantitative Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Cell-based Neutralization Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. LCMS Method Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Discovery Phase Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. LCMS Sample Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. GCP Bioanalysis Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Biomarker Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. Protein Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOANALYTICAL SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Small Molecule Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Large Molecule Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOANALYTICAL SERVICES MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Pharma & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOANALYTICAL SERVICES MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Service
    • 7.2.2 By Type
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Service
    • 7.3.2 By Type
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Spain
    • 7.3.9 Russia
    • 7.3.10 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Service
    • 7.4.2 By Type
    • 7.4.3 By End-user
    • 7.4.4 China
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 India
    • 7.4.8 Australia
    • 7.4.9 South East Asia
    • 7.4.10 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Service
    • 7.5.2 By Type
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Service
    • 7.6.2 By Type
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOANALYTICAL SERVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Labcorp
    • 9.2.2 Thermo Fisher Scientific Inc. (PPD)
    • 9.2.3 Charles River Laboratories International Inc
    • 9.2.4 Eurofins Scientific
    • 9.2.5 ICON Plc
    • 9.2.6 IQVIA Inc
    • 9.2.7 SGS SA
    • 9.2.8 Syneos Health
    • 9.2.9 WuXi AppTec
    • 9.2.10 Intertek Group Plc
    • 9.2.11 Medpace HoldingsInc
    • 9.2.12 Pace Analytical Services LLC
    • 9.2.13 Frontage Laboratories Inc
    • 9.2.14 BioAgilytix Labs
    • 9.2.15 Altasciences
    • 9.2.16 Almac Group
    • 9.2.17 Celerion
    • 9.2.18 Pharmaron
    • 9.2.19 LGC Limited
    • 9.2.20 KCAS Bioanalytical And Biomarker Services